
News|Articles|October 28, 2024
ICP-MS and ICP-OES: Tools for Elemental Impurity Analysis
Author(s)Alcami
Elemental impurity testing is essential to deliver safe drug products to patients and is a regulatory requirement. It is important to assess the risk of elemental impurities from all sources in the manufacturing process, including process equipment, water, container/packaging, raw materials, drug substances, and the final drug product.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
AI, CRISPR, and mRNA Driving Biotech’s Smartest Decade Yet
2
Conjugation and Regulation Challenges for Advanced Molecules: Part Two of Three with Abzena
3
Top BP Videos of 2025: An Intersection of AI, Innovation, and Compliance
4
FAQ: Understanding Biosimilars, Biobetters, and Interchangeability
5